Posaconazole (POS) 4-[4-[4-[4-[[(3R,5R)-5-(2,4-difluorophenyl)tetrahydro-5-(1H-1,2,4-triazol-1-ylmethyl)-3-furanyl]methoxy]phenyl]-1-piperazinyl]phenyl]-2-[(1S,2S)-1-ethyl-2- hydroxypropyl]-2,4-dihydro-3H-1,2,4-triazol-3-one (Fig.1)[1].Available under the brand names Noxafil oral suspension(40mg per mL) and Noxafil 100mg Gastro-resistant tablets [2] from the MSD (Merck Sharp & Dohme Ltd, Hertford Road, Hoddesdon Hertfordshire EN11 9BU United Kingdom)- Used for the Prevention of invasive Aspergillus and Candida infections in severely immune compromised adults and adolescents ≥13 years of age, including hematopoietic stem cell transplant (HSCT) recipients with graft-versus-host-disease (GVHD) and patients with hematologic malignancies and prolonged chemotherapy-associated neutropenia[3],[4],[5] The administration of drug is done orally during or immediately following a full meal or liquid nutritional supplement. …show more content…
It is also recommended by ICH that all routine impurities at or above the 0.1 % level, should be identified through appropriate analytical methods [7], [8], and [9]. In the synthesis of Posaconazole, the process related impurities are identified by MSN laboratories, they are Hydroxytriazole, Tosylated compound, Deshydroxy posaconazole and Benzylated posaconazole. (Fig.1) [10]. Therefore, it was thought worth determining the impurities of Posaconazole to ensure the quality, efficacy and safety of the active ingredient and final pharmaceutical formulation. The four processes related impurities, a method for analyzing Posaconazole in the presence of these impurities, and the degradants obtained during forced degradation studies was required to be developed for the method is to be stability